Dengue Academy

Battling #Dengue in a Warmer World: Shedding Light on #WorldMosquitoDay: Did you know that each year August 20th marks World Mosquito Day, commemorating the 1897 discovery by a British doctor, Sir Ronald Ross, of the malaria parasite in a dissected Anopheles mosquito? By establishing the link between female anopheline mosquitoes and malaria transmission between humans, this heralded over a century of research and work to understand and mitigate not only malaria infections but a whole raft of mosquito-borne diseases. Unprecedented global phenomena have since exacerbated the mosquito threat to public health, ranging from international movements of people and goods, the great global urban shift and a steadily changing climate. Simultaneously, our understanding and toolbox to tackle mosquito-borne diseases is rapidly expanding and we stand at an exciting inflection point in terms of the global response to this elusive and persistent threat to human health. Whilst substantial progress in this field has been achieved and must be celebrated, World Mosquito Day also provides a stark reminder that an additional 500 million people worldwide could be at risk of disease-carrying mosquitoes by 2050. Ahead of World Mosquito Day 2024, it has been my pleasure to partner with the Asia Venture Philanthropy Network AVPN to unpack some of these issues through the lens of dengue fever, the world's fastest-growing mosquito-borne disease, currently causing a never-seen-before number of infections worldwide and placing over half the world's population at risk. I would also love to read your thoughts and comments on these questions which will undoubtedly affect us all in some way. "Battling Dengue in a Warmer World": https://lnkd.in/eGsMM-wB #malaria #dengue #mosquito #climatechange #anopheles #aedes

If you missed our Dengue Academy Masterclass session on Dengue Prevention: Vaccination As Part Of A Comprehensive Strategy For Disease Control you can now watch the full video on the Dengue Academy website https://lnkd.in/er5ZY2p5 #dengueacademy #denguemasterclass #dengueprevention This non-promotional educational series was organized and funded by Takeda Pharmaceuticals International AG, including the payment of external speakers as consultants. Events were intended for a professional medical and scientific audience outside of the US and UK and not for members of the general public.

Vaccines Beat WHAT IS DENGUE?

The World Health Organization informed recently about the latest global dengue situation. As of 30 April 2024, over 7.6 million dengue cases have been reported to WHO in 2024, including 3.4 million confirmed cases, over 16 000 severe cases, and over 3000 deaths. While a substantial increase in dengue cases has been reported globally in the last five years, this increase has been particularly pronounced in the Region of the Americas, where the number of cases has already exceeded seven million by the end of April 2024, surpassing the annual high of 4.6 million cases in 2023. Visit dengueacademy.com and learn more about dengue (for an international audience of healthcare professionals outside of the US and UK) #dengue #denguefever #dengueacademy #globaldengue

If you missed our Dengue Academy Masterclass session on Dengue in Travelers you can now watch the full video on the Dengue Academy website https://lnkd.in/epCYzcRg #dengueacademy #denguemasterclass #dengueprevention This non-promotional educational series was organized and funded by Takeda Pharmaceuticals International AG, including the payment of external speakers as consultants. Events were intended for a professional medical and scientific audience outside of the US and UK and not for members of the general public.

If you missed our Dengue Academy Masterclass session with Somia Iqtadar and xavier saez-llorens on Emerging Issues in Dengue Control you can now watch the full video on the Dengue Academy website https://lnkd.in/dHhiimP3 #dengueacademy #denguemasterclass #dengueprevention This non-promotional educational series was organized and funded by Takeda Pharmaceuticals International AG, including the payment of external speakers as consultants. Events were intended for a professional medical and scientific audience outside of the US and UK and not for members of the general public.

Upstate’s Dr. Stephen Thomas kicks off the 3-day international dengue summit happening in Syracuse. Some of the world’s leading experts are in attendance to discuss the current dengue crisis, potential vaccines and other countermeasures to fight the mosquito-borne disease 🦠 🦟

Sohail et al. (2024) examined recent epidemiological trends in imported and locally acquired dengue in Australia. Imported cases were primarily acquired in Southeast Asia (n = 9323; 74%), Southern and Central Asia (n = 1555; 12%) and Oceania (n = 1341; 11%). Indonesia (n = 5778; 46%) and Thailand (n = 1483; 12%) were top acquisition countries. DENV-2 (n = 2147; 42%) and DENV-1 (n = 1526; 30%) were predominant serotypes. Visit dengueacademy.com and learn more about dengue (for an international audience of healthcare professionals outside of the US and UK) #dengue #denguefever #dengueacademy #australia

Some of the world’s leading experts on dengue will participate in an international dengue summit Aug. 7 through 9 at SUNY Upstate Medical University.

A recent post by Alessandro Albieri made me want to look at Europe #aedes #mosquito maps in a bit more detail, and see whether there are high level trends that seem to be emerging. One thing is clear - regions where aedes #aegypti (gif 1 below) and aedes #albopictus (gif 2 below) exist are increasing, and this increases the risk of aedes borne diseases such as #dengue, #Zika, #chikungunya and #YellowFever being transmitted. For A. Aegypti, there haven't been that many changes since the beginning of 2023, and it's encouraging to see more regions report data showing that the species is absent. However, one region of the #Netherlands has reported that A. Aegypti has now been introduced. The fact that this district isn't bordering another district in which the vector is present suggests that the introduction may be novel, or surveillance activities haven't found any samples (so it may exist more broadly). A. Albopictus, on the other hand, is picking up significantly in Europe. There are more and more districts in which A. Albopictus is being introduced, and becoming established. I was very surprised to see that areas of the UK have seen introduction of the vector, presumably this is from transport links with France. These trends highlight the urgent need to introduce and strengthen #VectorControl so as to prevent novel pathogens from being established and introducing new challenges to already strained health systems.